Gene · 2864
Papers1,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 17,18-epoxyeicosatetraenoic acid ameliorates mRNA-LNP-induced local inflammation by inhibiting neutrophil infiltration. | J Lipid Res | 2026 | 41354324 | PubTator, text mining | PubMed |
| Bidirectional regulation of free fatty acid receptors and non-alcoholic fatty liver disease. | J Nutr Biochem | 2026 | 41224148 | PubTator, text mining | PubMed |
| GPR39 and GPR40 in epilepsy: a potential therapeutic target for rational drug design, pathophysiology, current understanding and challenges. | Biochem Pharmacol | 2026 | 41213408 | PubTator, text mining | PubMed |
| Regulation of P450-derived epoxy fatty acids in cardiovascular diseases. | Redox Biochem Chem | 2025 | 42006847 | PubTator, text mining | PubMed |
| 4-HNE-induced cellular dysfunction from lipid peroxidation: a potential therapeutic target in diabetic cardiomyopathy. | Front Cell Dev Biol | 2025 | 41552010 | PubTator, text mining | PubMed |
| Pharmacologic Therapies for Type 2 Diabetes. | NEJM Evid | 2025 | 41538779 | PubTator, text mining | PubMed |
| Divergent Regulation of Mammary Lipogenesis by trans-10, cis-12 and cis-9, trans-11 CLA Isomers Is Determined by Receptor-Specific Signaling. | Animals (Basel) | 2025 | 41375476 | PubTator, text mining | PubMed |
| Perspective for Modulation of Hypothalamic Neurogenesis: Integrating Anatomical Insights with Exercise and Dietary Interventions. | Int J Mol Sci | 2025 | 41303399 | PubTator, text mining | PubMed |
| Hypoglycemic and Analgesic Effects of Benzyloxyphenylpropanoic Derivatives of Isobornylamine as FFAR-1 Agonists. | Arch Pharm (Weinheim) | 2025 | 41262055 | PubTator, text mining | PubMed |
| Precision Therapeutics Through Bioactive Compounds: Metabolic Reprogramming, Omics Integration, and Drug Repurposing Strategies. | Int J Mol Sci | 2025 | 41155339 | PubTator, text mining | PubMed |
| Screening of metabolic markers in pediatric epilepsy disorders. | J Transl Med | 2025 | 41024160 | PubTator, text mining | PubMed |
| Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning. | Elife | 2025 | 40982369 | PubTator, text mining | PubMed |
| The role of intrinsically disordered domains in regulating G protein coupled receptor signaling. | bioRxiv | 2025 | 40964316 | PubTator, text mining | PubMed |
| Combined agonism of nutrient receptors GPR40 and GPR119 with K-757 and K-833 results in weight loss and blood pressure reductions in obese subjects without type 2 diabetes mellitus. | Diabetes Obes Metab | 2025 | 40954563 | PubTator, text mining | PubMed |
| Highly Efficient and Cost-Effective Solid-Base CaO-MgO Catalyst for Knoevenagel Condensation in Water with a Good E‑Factor. | ACS Omega | 2025 | 40821545 | PubTator, text mining | PubMed |
| Combined GPR40 and GPR119 full agonism with K-757 and K-833 results in robust glucose lowering and modest weight loss in overweight/obese subjects with T2DM. | Diabetes Obes Metab | 2025 | 40767101 | PubTator, text mining | PubMed |
| Enantioselective Propargylic Substitution of Ketone Enolates with Propargylic Alcohol Derivatives through Cooperative B/Cu Catalysis. | Org Lett | 2025 | 40712127 | PubTator, text mining | PubMed |
| Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders. | J Med Chem | 2025 | 40708100 | PubTator, text mining | PubMed |
| Correction to "Pla2g5 Contributes to Viral-Like-Induced Lung Inflammation Through Macrophage Proliferation and LA/Ffar1 Lung Cell Recruitment". | Immunology | 2025 | 40707417 | PubTator, text mining | PubMed |
| The role of free fatty acid receptors activation in pancreatic disorders. | Mol Aspects Med | 2025 | 40652884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2864/papers?page=2